These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 20974993
1. Effect of citrus juice and SLCO2B1 genotype on the pharmacokinetics of montelukast. Mougey EB, Lang JE, Wen X, Lima JJ. J Clin Pharmacol; 2011 May; 51(5):751-60. PubMed ID: 20974993 [Abstract] [Full Text] [Related]
2. SLCO2B1 c.935G>A single nucleotide polymorphism has no effect on the pharmacokinetics of montelukast and aliskiren. Tapaninen T, Karonen T, Backman JT, Neuvonen PJ, Niemi M. Pharmacogenet Genomics; 2013 Jan; 23(1):19-24. PubMed ID: 23151832 [Abstract] [Full Text] [Related]
3. Effects of polymorphisms of the SLCO2B1 transporter gene on the pharmacokinetics of montelukast in humans. Kim KA, Lee HM, Joo HJ, Park IB, Park JY. J Clin Pharmacol; 2013 Nov; 53(11):1186-93. PubMed ID: 23970434 [Abstract] [Full Text] [Related]
4. Gemfibrozil markedly increases the plasma concentrations of montelukast: a previously unrecognized role for CYP2C8 in the metabolism of montelukast. Karonen T, Filppula A, Laitila J, Niemi M, Neuvonen PJ, Backman JT. Clin Pharmacol Ther; 2010 Aug; 88(2):223-30. PubMed ID: 20592724 [Abstract] [Full Text] [Related]
5. Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response. Mougey EB, Feng H, Castro M, Irvin CG, Lima JJ. Pharmacogenet Genomics; 2009 Feb; 19(2):129-38. PubMed ID: 19151602 [Abstract] [Full Text] [Related]
6. Effect of clarithromycin and fluconazole on the pharmacokinetics of montelukast in human volunteers. Hegazy SK, Mabrouk MM, Elsisi AE, Mansour NO. Eur J Clin Pharmacol; 2012 Sep; 68(9):1275-80. PubMed ID: 22392555 [Abstract] [Full Text] [Related]
7. Effect of grapefruit juice on bioavailability of montelukast. Cingi C, Toros SZ, Gürbüz MK, Ince I, Cakli H, Erdogmus N, Karasulu E, Kaya E. Laryngoscope; 2013 Apr; 123(4):816-9. PubMed ID: 22951980 [Abstract] [Full Text] [Related]
8. Montelukast pharmacokinetics in cystic fibrosis. Graff GR, Weber A, Wessler-Starman D, Smith AL. J Pediatr; 2003 Jan; 142(1):53-6. PubMed ID: 12520255 [Abstract] [Full Text] [Related]
9. Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides. Dresser GK, Kim RB, Bailey DG. Clin Pharmacol Ther; 2005 Mar; 77(3):170-7. PubMed ID: 15735611 [Abstract] [Full Text] [Related]
11. Pharmacokinetics and safety of montelukast in children aged 3 to 6 months. Knorr B, Maganti L, Ramakrishnan R, Tozzi CA, Migoya E, Kearns G. J Clin Pharmacol; 2006 Jun; 46(6):620-7. PubMed ID: 16707408 [Abstract] [Full Text] [Related]
14. Developmental Pharmacogenetics of SLCO2B1 on Montelukast Pharmacokinetics in Chinese Children. Li Q, Wang K, Shi HY, Wu YE, Zhou Y, Kan M, Zheng Y, Hao GX, Yang XM, Yang YL, Su LQ, Wang XL, Jacqz-Aigrain E, Zhou J, Zhao W. Drug Des Devel Ther; 2019 Jun; 13():4405-4411. PubMed ID: 31920289 [Abstract] [Full Text] [Related]
16. Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. Bailey DG, Dresser GK, Leake BF, Kim RB. Clin Pharmacol Ther; 2007 Apr; 81(4):495-502. PubMed ID: 17301733 [Abstract] [Full Text] [Related]
17. Effect of multiple doses of montelukast on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in humans. Kim KA, Park PW, Kim KR, Park JY. Br J Clin Pharmacol; 2007 Mar; 63(3):339-45. PubMed ID: 16981900 [Abstract] [Full Text] [Related]